AI Insight
Researchers identified ZC3H10, a zinc-finger protein, as a negative regulator that suppresses the body's interferon response during viral infections. Through genome-wide screening and experimental validation, they demonstrated that ZC3H10 directly binds to specific DNA sequences in interferon-stimulated gene promoters, preventing their activation and thereby dampening antiviral immunity. When ZC3H10 was removed, cells showed enhanced resistance to multiple viruses including SARS-CoV-2, Newcastle disease virus, and rhinovirus.
Why it matters
This discovery reveals a molecular brake on the immune system's antiviral response, which could inform therapeutic strategies for treating viral infections by targeting ZC3H10 to boost immunity, or conversely, for managing autoimmune conditions where excessive interferon signaling causes harm.
Understand the Science
by Xiaojing Dong, Xiaoyan Zuo, Xia Xiao, Shichao Ma, Lili Ren, Zhuo Zhou, Xiaobo Lei, Jianwei Wang
Type I interferons (IFNs) play a central role in antiviral immunity by activating the JAK-STAT signaling pathway to induce interferon-stimulated genes (ISGs). Precise regulation of this response is critical to avoid pathological inflammation and autoimmunity, but the molecular mechanisms that restrain IFN signaling remain incompletely defined. Here, we performed a human whole-genome cDNA library screen and identified ZC3H10 as a negative regulator of the type I IFN response. Overexpression of ZC3H10 suppressed ISG expression following IFNβ stimulation and increased susceptibility to infection by Newcastle disease virus, human rhinovirus 16, Enterovirus A71, and SARS-CoV-2, whereas genetic deletion of ZC3H10 enhanced ISG expression and antiviral resistance. Mechanistically, ZC3H10 required nuclear localization, a functional nucleic acid-binding domain, and its coiled-coil domain to exert its inhibitory function. Furthermore, chromatin immunoprecipitation assays revealed that ZC3H10 directly binds to the TTTC motif within ISG promoters, thereby preventing their activation. Together, these findings establish ZC3H10 as a critical negative regulator of IFN signaling that functions to balance antiviral immunity.